X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1167) 1167
Publication (137) 137
Newspaper Article (117) 117
Newsletter (62) 62
Book Review (39) 39
Book Chapter (34) 34
Book / eBook (12) 12
Conference Proceeding (7) 7
Magazine Article (3) 3
Data Set (2) 2
Dissertation (2) 2
Report (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
vaccines (768) 768
humans (719) 719
index medicus (680) 680
animals (586) 586
immunology (585) 585
vaccination (336) 336
influenza (335) 335
antigens (333) 333
female (327) 327
immunization (279) 279
mice (271) 271
vaccine (269) 269
immunogenicity (267) 267
medicine, research & experimental (252) 252
proteins (229) 229
influenza vaccines - immunology (215) 215
immune response (206) 206
infectious diseases (195) 195
adjuvants, immunologic - administration & dosage (187) 187
viruses (185) 185
influenza vaccines (184) 184
influenza vaccines - administration & dosage (181) 181
dendritic cells (174) 174
male (170) 170
health aspects (166) 166
adjuvant (160) 160
antibodies, viral - blood (160) 160
allergy and immunology (158) 158
mice, inbred balb c (156) 156
infections (154) 154
immune system (149) 149
immune-responses (144) 144
research (144) 144
adjuvants (139) 139
vaccines, virosome - immunology (136) 136
influenza, human - prevention & control (135) 135
medical research (133) 133
antibodies (126) 126
virology (126) 126
infection (124) 124
biotechnology & applied microbiology (119) 119
immunity (118) 118
adult (117) 117
virus-like particles (114) 114
safety (113) 113
drug delivery systems (111) 111
pharmacology & pharmacy (110) 110
vaccines, virosome - administration & dosage (104) 104
vaccination - methods (99) 99
vaccines - immunology (99) 99
medicine (98) 98
microbiology (98) 98
clinical trials (97) 97
virosomes (96) 96
immunotherapy (93) 93
influenza vaccine (93) 93
cancer (92) 92
nanoparticles (92) 92
prevention (92) 92
administration, intranasal (91) 91
medicine, experimental (91) 91
virus diseases (90) 90
analysis (89) 89
children (89) 89
immune-response (88) 88
review (88) 88
vaccines - administration & dosage (88) 88
influenza vaccines - adverse effects (87) 87
t cells (85) 85
peptides (84) 84
adolescent (83) 83
liposomes (83) 83
child (82) 82
studies (80) 80
adjuvants, immunologic - pharmacology (79) 79
antibody-responses (76) 76
middle aged (75) 75
aged (73) 73
malaria (72) 72
efficacy (70) 70
vaccines, inactivated - immunology (70) 70
immunoglobulin g (69) 69
immunoglobulins (69) 69
child, preschool (68) 68
pandemics (68) 68
protection (68) 68
research & development--r&d (68) 68
adjuvants, immunologic (67) 67
hepatitis (66) 66
lymphocytes (66) 66
biology (65) 65
enzyme-linked immunosorbent assay (65) 65
lipids (65) 65
public health (65) 65
research article (65) 65
antigen (64) 64
immunoglobulin g - blood (64) 64
t-cell responses (64) 64
article (63) 63
viral vaccines - immunology (63) 63
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1392) 1392
German (3) 3
Russian (3) 3
French (2) 2
Italian (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 02/2011, Volume 34, Issue 2, pp. 269 - 280
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2003, Volume 21, Issue 9, pp. 921 - 924
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22273
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 41, pp. 7154 - 7162
Highlights ► A rapid method for VLP vaccine preparation comprising bacterial expression and in vitro self assembly is reported. ► Chimeric VLPs and capsomeres... 
Allergy and Immunology | Virus | Particle | Vaccine | Streptococcus | Manufacture | Influenza | STRUCTURAL PROTEIN | MEDICINE, RESEARCH & EXPERIMENTAL | ESCHERICHIA-COLI | VIRAL PROTEIN | M PROTEIN | IMMUNOLOGY | SMALLPOX ERADICATION | HUMAN-ANTIBODIES | GROUP-A STREPTOCOCCUS | FIELD FLOW FRACTIONATION | CONSERVED REGION | INFLUENZA-VIRUS | Viral Matrix Proteins - genetics | Antigens, Bacterial - immunology | Antibodies, Viral - blood | Antigens, Bacterial - genetics | Streptococcus pyogenes - genetics | Virosomes - metabolism | Biotechnology - methods | Vaccines, Virosome - immunology | Female | Viral Matrix Proteins - metabolism | Antibodies, Bacterial - blood | Genetic Engineering - methods | Recombinant Proteins - metabolism | Gene Expression | Capsid Proteins - metabolism | Streptococcus pyogenes - immunology | Vaccines, Virosome - administration & dosage | Polyomavirus - genetics | Technology, Pharmaceutical - methods | Recombinant Proteins - genetics | Polyomavirus - metabolism | Vaccines, Virosome - genetics | Animals | Escherichia coli - genetics | Virosomes - genetics | Vaccines, Virosome - metabolism | Mice | Viral Matrix Proteins - immunology | Antigens, Bacterial - metabolism | Capsid Proteins - genetics | Antigens | Vaccines | Cell culture | Immunization | Pandemics | Disease | Peptides | Mortality | Viruses | Developing countries--LDCs | E coli | Protein folding | Bacteria | Manufacturing | Antigen presentation | Pathogens | VP1 protein | Structural proteins | Antibodies | Insertion | protein purification | Adjuvants | Intranasal administration | Geographical variations | Self | Virus-like particles | Bioreactors | Drying
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 3, pp. 524 - 532
Highlights ► This Phase 1 trial evaluated the safety and immunogenicity of an RSV (F) nanoparticle vaccine. ► The vaccine was well-tolerated and no related... 
Allergy and Immunology | Respiratory syncytial virus (RSV) | Palivizumab | Fusion protein (F protein) | Competitive ELISA | SF9 insect cell | Microneutralization | Aluminum phosphate | Anti-F IgG | Nanoparticle vaccine | UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | IMMUNE GLOBULIN | COTTON RATS | INFLUENZA | RISK | IMMUNOLOGY | F-GLYCOPROTEIN | INFANTS | INFECTION | YOUNG-CHILDREN | Recombinant Fusion Proteins - immunology | Single-Blind Method | Biotechnology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Aluminum Compounds - adverse effects | Phosphates - administration & dosage | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Nanoparticles - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Adjuvants, Immunologic - adverse effects | Young Adult | Respiratory Syncytial Virus Vaccines - adverse effects | Sf9 Cells | Technology, Pharmaceutical | Vaccines, Virosome - immunology | Vaccines, Synthetic - adverse effects | Placebos - adverse effects | Adult | Female | Placebos - administration & dosage | Recombinant Fusion Proteins - administration & dosage | Vaccines, Virosome - administration & dosage | Vaccines, Synthetic - genetics | Vaccines, Virosome - genetics | Animals | Aluminum Compounds - administration & dosage | Phosphates - adverse effects | Vaccines, Virosome - adverse effects | Respiratory Syncytial Virus Vaccines - administration & dosage | Adolescent | Recombinant Fusion Proteins - genetics | Nanoparticles - administration & dosage | Vaccines, Synthetic - administration & dosage | Respiratory Syncytial Virus Vaccines - genetics | Antibodies, Neutralizing - blood | Virus diseases | Phosphates | Vaccines | Immunoglobulin G | Enzyme-linked immunosorbent assay | Proteins | Nanoparticles | Infections | Index Medicus
Journal Article